Next, a Kaplan‒Meier analysis revealed that lung cancer patients with high expression levels of ALKBH5 had shorter overall survival (OS) than those with low expression levels of ALKBH5 (Fig. 1C). The gene discussed is ALKBH5; the disease is lung cancer.